1. Additional file 1 of Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
- Author
-
Bhargava, Mudit, Kopp, Chirag Rajkumar, Naidu, Shankar, Dhibar, Deba Prasad, Saroch, Atul, Khadwal, Alka, Narang, Tarun, Jain, Siddharth, Khullar, Aastha, Leishangthem, Bidya, Sharma, Aman, Kumar, Susheel, Sharma, Shefali, Jain, Sanjay, and Dhir, Varun
- Abstract
Additional file 1: Table S1. Causes of death in the 17 patients who died in the first 30-days after randomization. Table S2. Receiver-Operating-Curve Analysis for serum albumin to predict survival. Area-under-curve=0.75, p=0.01. Figure Supplementary 1. Kaplan-meier survival curves showing time-to-event curves of oral ulcer recovery in the two groups. (log-rank test p =0.40, median estimate to mucositis recovery in days was 4, 5 days). Figure Supplementary 2. Kaplan-Meier survival curves showing time-to-event curves of WBC recovery (≥4 x 10^9/L) in the two groups. (log-rank test p =0.07, median estimate to WBC recovery in days was 4, 6 days). Figure Supplementary 3. Kaplan-meier survival curves showing time-to-event curves of partial platelet recovery (≥50 x 10^9/L) in the two groups.(log-rank test p =0.86, median estimate in days to platelet recovery in leucovorin 15 and 25 mg groups was 4, 4 days). Figure Supplementary 4. Kaplan-meier survival curves showing time-to-event curves of both WBC (≥4 x 10^9/L) and platelet recovery (≥50 x 10^9/L) in the two groups. (Log-rank test p=0.50, Median estimate in days in leucovorin 15 and 25 mg groups to both EBC and partial platelet recovery was 5, 6 days). Figure S5. Methotrexate polyglutamate 1-3 levels determined by HPLC.
- Published
- 2023
- Full Text
- View/download PDF